Posted On: 05/18/2014 3:59:07 PM
Post# of 44875
$PPCH OUR ADVANTAGE - PRP was developed because of the limitation of current cancer therapies. While surgery is often safe and effective, many standard therapies for late stage cancer patients urgently need improvement; with current treatments generally providing modest benefits, and frequently causing significant adverse effects.
Our focus is to provide oncologists and their patients with therapies for metastatic cancer which are more effective than current therapies, and which have a substantially better side effect profile.
Propanc is currently completing non clinical studies and intends to undertake Phase I, II and III clinical trials to assess the safety and efficacy of our product in specific patient populations.
http://www.propanc.com/who-we-are/our-advantage.php
Our focus is to provide oncologists and their patients with therapies for metastatic cancer which are more effective than current therapies, and which have a substantially better side effect profile.
Propanc is currently completing non clinical studies and intends to undertake Phase I, II and III clinical trials to assess the safety and efficacy of our product in specific patient populations.
http://www.propanc.com/who-we-are/our-advantage.php
(0)
(0)Scroll down for more posts ▼
